DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,520,078 | +5.2% | 6,127 | +1.8% | 0.26% | +7.8% |
| Q2 2023 | $1,444,320 | -4.7% | 6,018 | +0.0% | 0.24% | -9.3% |
| Q1 2023 | $1,515,980 | -4.7% | 6,015 | +0.4% | 0.27% | -10.0% |
| Q4 2022 | $1,590,830 | +4.2% | 5,994 | +1.4% | 0.30% | -8.5% |
| Q3 2022 | $1,527,000 | +16.9% | 5,911 | +14.8% | 0.33% | +23.3% |
| Q2 2022 | $1,306,000 | +10.7% | 5,151 | +28.0% | 0.27% | +41.5% |
| Q1 2022 | $1,180,000 | +62.1% | 4,023 | +81.8% | 0.19% | +67.9% |
| Q4 2021 | $728,000 | +147.6% | 2,213 | +129.3% | 0.11% | +133.3% |
| Q3 2021 | $294,000 | +70.9% | 965 | +50.3% | 0.05% | +71.4% |
| Q2 2021 | $172,000 | +19.4% | 642 | 0.0% | 0.03% | +12.0% |
| Q1 2021 | $144,000 | +33.3% | 642 | +32.1% | 0.02% | +31.6% |
| Q4 2020 | $108,000 | +1.9% | 486 | -1.6% | 0.02% | -5.0% |
| Q3 2020 | $106,000 | -51.8% | 494 | -60.4% | 0.02% | -53.5% |
| Q2 2020 | $220,000 | -36.6% | 1,246 | -49.4% | 0.04% | +7.5% |
| Q1 2020 | $347,000 | +83.6% | 2,464 | +100.0% | 0.04% | +8.1% |
| Q4 2019 | $189,000 | +6.2% | 1,232 | 0.0% | 0.04% | -2.6% |
| Q3 2019 | $178,000 | +1.1% | 1,232 | 0.0% | 0.04% | -5.0% |
| Q2 2019 | $176,000 | -3.3% | 1,232 | -10.5% | 0.04% | -2.4% |
| Q1 2019 | $182,000 | +27.3% | 1,376 | -0.5% | 0.04% | +13.9% |
| Q4 2018 | $143,000 | -3.4% | 1,383 | +1.8% | 0.04% | +5.9% |
| Q3 2018 | $148,000 | -9.2% | 1,359 | -17.7% | 0.03% | -17.1% |
| Q2 2018 | $163,000 | -8.4% | 1,652 | -9.1% | 0.04% | -6.8% |
| Q1 2018 | $178,000 | -5.3% | 1,817 | -10.1% | 0.04% | -2.2% |
| Q4 2017 | $188,000 | -18.3% | 2,022 | -24.7% | 0.04% | -21.1% |
| Q3 2017 | $230,000 | -70.5% | 2,687 | -70.9% | 0.06% | -71.8% |
| Q2 2017 | $780,000 | -75.8% | 9,242 | -75.5% | 0.20% | -75.8% |
| Q1 2017 | $3,225,000 | +8.9% | 37,706 | -0.9% | 0.84% | +5.6% |
| Q4 2016 | $2,961,000 | -2.3% | 38,035 | -1.6% | 0.79% | -7.1% |
| Q3 2016 | $3,030,000 | -18.5% | 38,662 | +5.0% | 0.85% | -20.4% |
| Q2 2016 | $3,719,000 | +2239.0% | 36,826 | +2101.2% | 1.07% | +2329.5% |
| Q1 2016 | $159,000 | +7.4% | 1,673 | +5.2% | 0.04% | +2.3% |
| Q4 2015 | $148,000 | +9.6% | 1,590 | 0.0% | 0.04% | -4.4% |
| Q3 2015 | $135,000 | -0.7% | 1,590 | 0.0% | 0.04% | +4.7% |
| Q2 2015 | $136,000 | +0.7% | 1,590 | 0.0% | 0.04% | -4.4% |
| Q1 2015 | $135,000 | – | 1,590 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |